Agrawal 2002.

Methods	Generation of allocation sequence: not stated. Blinding: double blind, decoded, identical active herbal product and placebo. Sample size estimation: no information. Withdrawal/drop‐out: unstated.
Participants	Ethnic: Hindu; 60 patients (30 in treatment group, M/F 22/8; mean age 45 years; 30 in placebo group, M/F 24/6, mean age 47 years). Setting: unstated. Inclusion criteria: newly diagnosed NIDDM patients (diagnostic criteria unstated). Exclusion criteria: unstated.
Interventions	Experimental intervention: Inolter (containing five herbs) capsule, no details for the usage, for three months. Control intervention: Placebo (identical to Inolter), no details usage, for three months. All patients were managed with diet and exercise regimen during the study period.
Outcomes	FBG, HbA1c, serum cholesterol, and adverse effect.
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear